Effects of tacrolimus on hyperlipidemia after successful renal transplantation: A southeastern organ procurement foundation multicenter clinical study Academic Article Article uri icon

Overview

MeSH Major

  • Ambulatory Care
  • Ambulatory Care Facilities
  • Organ Transplantation
  • Remote Consultation

abstract

  • Conversion from cyclosporine to tacrolimus can be safely done after successful transplantation. Introduction of tacrolimus to a stable renal patient does not effect renal function or glycemic control. Tacrolimus can lower cholesterol, LDL, and apolipoprotein B. Conversion to tacrolimus from cyclosporine should be considered in the treatment of posttransplant hyperlipidemia.

publication date

  • January 15, 1998

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1097/00007890-199801150-00017

PubMed ID

  • 9448150

Additional Document Info

start page

  • 87

end page

  • 92

volume

  • 65

number

  • 1